skip to content
Primary navigation


Drug - Eucrisa™ (crisaborole) [Anacor]

June 2017

Therapeutic area - Atopic Dermatitis

Approval criteria

  • Must be 2 years of age or older AND
  • Have a diagnosis of atopic dermatitis AND
  • Be prescribed by a dermatologist AND prescriber’s specialty must be provided at time of request AND
  • Trial and failure of TWO topical corticosteroids AND ONE topical calcineurin inhibitors OR
  • Trial of TWO topical corticosteroids or a contraindication to topical steroid use. Contraindications include:
    • Treatment of sensitive areas (face, anogenital, skin folds)
    • Steroid induced atrophy
    • Long-term uninterrupted use AND
  • Trial of ONE topical calcineurin inhibitor or a contraindication to topical calcineurin use. Contraindications include:
    • Severely impaired skin barrier (Netherton Syndrome)
    • Risk/Presence of malignancy

Quantity limits

60 g or 100 g tube: one tube per 34 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top